share_log

THC Biomed Intl Ltd. (OTCMKTS:THCBF) Sees Significant Increase in Short Interest

Financial News Live ·  Sep 29, 2022 22:02

THC Biomed Intl Ltd. (OTCMKTS:THCBF – Get Rating) was the recipient of a large increase in short interest in the month of September. As of September 15th, there was short interest totalling 3,300 shares, an increase of 560.0% from the August 31st total of 500 shares. Based on an average daily trading volume, of 22,900 shares, the short-interest ratio is presently 0.1 days.

THC Biomed Intl Stock Performance

OTCMKTS THCBF remained flat at $0.03 on Thursday. The company's stock had a trading volume of 7,262 shares, compared to its average volume of 18,961. THC Biomed Intl has a 12-month low of $0.02 and a 12-month high of $0.08. The company's fifty day moving average price is $0.04 and its 200 day moving average price is $0.04.

Get THC Biomed Intl alerts:

THC Biomed Intl Company Profile

(Get Rating)

THC Biomed Intl Ltd. produces and sells medical and recreational cannabis in Canada. It offers cannabis beverage shots, gummies, and biscuits under the THC KISS brand names, as well as pure cannabis sticks. THC Biomed Intl Ltd. was founded in 2012 and is headquartered in Kelowna, Canada.

See Also

  • Get a free copy of the StockNews.com research report on THC Biomed Intl (THCBF)
  • 2 Casino Stocks Worth Taking a Look At
  • This Small-Cap Healthcare Name Is Outperforming Its Index
  • What Cintas Can Teach Investors About This Bear Market?
  • Blackberry Stock Declines As Results Come In Lukewarm Once Again
  • A Trio of Q3 Winners With Room to Run

Receive News & Ratings for THC Biomed Intl Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for THC Biomed Intl and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment